$250 | Single User
$500 | Site License
$750 | Global License

AbbVie Inc (ABBV) - Medical Equipment - Deals and Alliances Profile [Report Updated: 26-02-2018]

Published by Global Data: 26 Feb 2018 | 195321 | In Stock

Introduction

Summary

AbbVie Inc (AbbVie) is a research-based biopharmaceutical company that carries out the research, development, manufacture and commercialization of advanced therapies to treat complex and serious diseases. The company focuses on providing drugs in immunology, cancer, neuroscience and virology and general medicine therapy areas. Its products are used to treat rheumatoid arthritis, juvenile idiopathic arthritis, ankylosing spondylitis, osteoarthritis, plaque psoriasis, psoriatic arthritis, hidradenitis suppurativa, Crohn’s disease, ulcerative colitis, systemic lupus erythematosus, chronic lymphocytic leukemia, small cell lung cancer, relapsed/refractory marginal zone lymphoma, Alzheimer’s disease, multiple sclerosis, Parkinson’s disease, hepatitis C (HCV), human immunodeficiency virus (HIV) and other serious health conditions. AbbVie sells its products worldwide directly to wholesalers, distributors, health care facilities, government agencies, specialty pharmacies and independent retailers through its owned distribution centers and public warehouses. The company operates through subsidiaries in North America, South America, Asia, Europe, Middle East and South Africa. AbbVie is headquartered in North Chicago, Illinois, the US.

AbbVie Inc (ABBV) - Medical Equipment - Deals and Alliances Profile provides you comprehensive data and trend analysis of the company's Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Medical eTrack deals database, and primary and secondary research.

Scope

- Financial Deals - Analysis of the company's financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.

- Deals by Year - Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.

- Deals by Type - Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.

- Deals by Region - Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.

- Deals by Sub-sector - Chart and table showing information on the number of deals and value reported by the company, by sub-sector.

- Major Deals - Information on the company's major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.

- Business Description - A brief description of the company's operations.

- Key Employees - A list of the key executives of the company.

- Important Locations and Subsidiaries - A list and contact details of key centers of operation and subsidiaries of the company.

- Key Competitors - A list of the key competitors of the company.

- Key Recent Developments - A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company's financial deals that enable you to understand the company's expansion/divestiture and fund requirements

- The profile enables you to analyze the company's financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company's business segments' expansion / divestiture strategy

- The profile presents deals from the company's core business segments' perspective to help you understand its corporate strategy.

Access elaborate information on the company's recent financial deals that enable you to understand the key deals which have shaped the company

- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company's key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.

- The profile analyzes the company's business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company

- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research

- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

Table of Contents
for AbbVie Inc (ABBV) - Medical Equipment - Deals and Alliances Profile [Report Updated: 26-02-2018]

  • Table of Contents

    Table of Contents 3

    List of Tables 5

    List of Figures 5

    AbbVie Inc, Medical Equipment, Deals By Year, 2012 to YTD 2018 6

    AbbVie Inc, Medical Equipment Deals By Type, 2012 to YTD 2018 7

    AbbVie Inc, Medical Equipment, Deals By Region, 2012 to YTD 2018 8

    AbbVie Inc, Medical Equipment, Deals By Market, 2012 to YTD 2018 9

    AbbVie Inc, Medical Equipment, Deals Summary, 2012 to YTD 2018 10

    AbbVie Inc, Medical Equipment, Deal Details 11

    Venture Financing 11

    Stem CentRx Raises more than USD100 Million in Financing Round 11

    Partnerships 12

    AbbVie Enters into Licensing Agreement with Cerveau Technologies 12

    Enterome Enters into Co-Development Agreement with AbbVie 13

    Abbott Molecular Enters Into Agreement With Janssen Biotech And Pharmacyclics For Leukemia Test 14

    Debt Offering 15

    AbbVie Raises USD795.6 Million in Public Offering of 2.13% Notes Due 2028 15

    AbbVie Raises USD1.53 Billion in Public Offering of 1.38% Notes Due 2024 16

    AbbVie Raises USD1.48 Billion in Public Offering of 0.38% Notes Due 2019 17

    AbbVie Raises USD1 Billion in Public Offering of 3.2% Notes Due 2022 18

    AbbVie Raises USD2.7 Billion in Public Offering of 4.7% Notes Due 2045 20

    AbbVie Raises USD3.75 Billion in Public Offering of 2.5% Notes Due 2020 22

    AbbVie Raises USD3 Billion in Public Offering of 1.8% Notes Due 2018 24

    AbbVie Raises USD3.75 Billion in Public Offering of 3.6% Notes Due 2025 26

    AbbVie Raises USD2.5 Billion in Public Offering of 4.5% Notes Due 2035 28

    AbbVie Raises USD4 Billion in Public Offering of 1.75% Notes Due 2017 30

    AbbVie Raises USD3.1 Billion in Public Offering of 2.9% Notes Due 2022 31

    AbbVie Raises USD2.6 Billion in Public Offering of 4.4% Notes Due 2042 32

    AbbVie Raises USD1 Billion in Public Offering of 2% Notes Due 2018 33

    AbbVie Inc - Key Competitors 34

    AbbVie Inc - Key Employees 35

    AbbVie Inc - Locations And Subsidiaries 36

    Head Office 36

    Other Locations & Subsidiaries 36

    Recent Developments 44

    Financial Announcements 44

    Jan 26, 2018: AbbVie Reports Full-Year and Fourth-Quarter 2017 Financial Results 44

    Oct 27, 2017: AbbVie Reports Third-Quarter 2017 Financial Results 46

    Jul 28, 2017: AbbVie Reports Second-Quarter 2017 Financial Results 48

    Apr 27, 2017: AbbVie Reports First-Quarter 2017 Financial Results 50

    Jan 27, 2017: AbbVie Reports Full-Year and Fourth-Quarter 2016 Financial Results 52

    Corporate Communications 54

    Sep 07, 2017: AbbVie Leads Biotechnology Industry on Dow Jones Sustainability Index for Second Consecutive Year 54

    Legal and Regulatory 55

    Jul 31, 2017: AbbVie Announces Delisting from Euronext Paris 55

    Product News 56

    May 17, 2017: AbbVie to Present Latest Clinical Study Results in Hematology and Solid Tumor Research at the 53rd American Society of Clinical Oncology Annual Meeting 56

    Appendix 58

    Methodology 58

    About GlobalData 58

    Contact Us 58

    Disclaimer 58

List Of Tables
in AbbVie Inc (ABBV) - Medical Equipment - Deals and Alliances Profile [Report Updated: 26-02-2018]

List of Tables

AbbVie Inc, Medical Equipment, Key Facts, 2016 2

AbbVie Inc, Medical Equipment, Deals Summary, 2012 to YTD 2018 2

AbbVie Inc, Medical Equipment, Deals By Year, 2012 to YTD 2018 6

AbbVie Inc, Medical Equipment Deals By Type, 2012 to YTD 2018 7

AbbVie Inc, Medical Equipment, Deals By Region, 2012 to YTD 2018 8

AbbVie Inc, Deals By Market, 2012 to YTD 2018 9

AbbVie Inc, Medical Equipment, Deals Summary, 2012 to YTD 2018 10

Stem CentRx Raises more than USD100 Million in Financing Round 11

AbbVie Enters into Licensing Agreement with Cerveau Technologies 12

Enterome Enters into Co-Development Agreement with AbbVie 13

Abbott Molecular Enters Into Agreement With Janssen Biotech And Pharmacyclics For Leukemia Test 14

AbbVie Raises USD795.6 Million in Public Offering of 2.13% Notes Due 2028 15

AbbVie Raises USD1.53 Billion in Public Offering of 1.38% Notes Due 2024 16

AbbVie Raises USD1.48 Billion in Public Offering of 0.38% Notes Due 2019 17

AbbVie Raises USD1 Billion in Public Offering of 3.2% Notes Due 2022 18

AbbVie Raises USD2.7 Billion in Public Offering of 4.7% Notes Due 2045 20

AbbVie Raises USD3.75 Billion in Public Offering of 2.5% Notes Due 2020 22

AbbVie Raises USD3 Billion in Public Offering of 1.8% Notes Due 2018 24

AbbVie Raises USD3.75 Billion in Public Offering of 3.6% Notes Due 2025 26

AbbVie Raises USD2.5 Billion in Public Offering of 4.5% Notes Due 2035 28

AbbVie Raises USD4 Billion in Public Offering of 1.75% Notes Due 2017 30

AbbVie Raises USD3.1 Billion in Public Offering of 2.9% Notes Due 2022 31

AbbVie Raises USD2.6 Billion in Public Offering of 4.4% Notes Due 2042 32

AbbVie Raises USD1 Billion in Public Offering of 2% Notes Due 2018 33

AbbVie Inc, Key Competitors 34

AbbVie Inc, Key Employees 35

AbbVie Inc, Subsidiaries 36

List Of Figures, Charts and Diagrams
in AbbVie Inc (ABBV) - Medical Equipment - Deals and Alliances Profile [Report Updated: 26-02-2018]

List of Figures

AbbVie Inc, Medical Equipment, Deals by Type, 2012 to YTD 2018 2

AbbVie Inc, Medical Equipment, Deals By Year, 2012 to YTD 2018 2

AbbVie Inc, Medical Equipment, Deals By Region, 2012 to YTD 2018 2

AbbVie Inc, Medical Equipment, Deals By Market, 2012 to YTD 2018 2

AbbVie Inc, Medical Equipment, Deals By Year, 2012 to YTD 2018 6

AbbVie Inc, Medical Equipment, Deals by Type, 2012 to YTD 2018 7

AbbVie Inc, Medical Equipment, Deals By Region, 2012 to YTD 2018 8

AbbVie Inc, Medical Equipment, Deals by Market, 2012 to YTD 2018 9

Additional Details

Publisher

Global Data

Publisher Information

Reference

195321 | GDME430057D

Number of Pages

58

Report Format

PDF

Global Data Reports

Related Reports

TitleDate PublishedPrice fromMore Details
Abbvie Partnering Deals and Alliances 2010 to 2016
The Partnering Deals and Alliance since 2010 report provides an in-depth insight into the partnering...
01 Oct 2016 by Current Partnering USD $1,495 More Info
AbbVie Inc. (ABBV) - Medical Equipment - Deals and Alliances Profile
SummaryAbbVie Inc. (AbbVie) is a research-based biopharmaceutical company that carries out the resea...
20 Jul 2016 by Global Data USD $250 More Info
AbbVie Inc. (ABBV) - Medical Equipment - Deals and Alliances Profile
SummaryAbbVie Inc. (AbbVie) is a research-based biopharmaceutical company that carries out the resea...
14 Apr 2016 by Global Data USD $250 More Info
AbbVie Inc. (ABBV) - Pharmaceuticals & Healthcare - Deals and Alliances Profile
SummaryAbbVie Inc. (AbbVie) is a research-based biopharmaceutical company that carries out the resea...
05 Apr 2016 by Global Data USD $250 More Info
AbbVie Inc. (ABBV) - Financial and Strategic SWOT Analysis Review
AbbVie Inc. (ABBV) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic...
22 Mar 2016 by Global Data USD $300 More Info
AbbVie Inc. (ABBV) - Pharmaceuticals & Healthcare - Deals and Alliances Profile
SummaryAbbVie Inc. (AbbVie) is a research-based biopharmaceutical company that carries out the resea...
03 Mar 2016 by Global Data USD $250 More Info
AbbVie Inc. (ABBV) - Medical Equipment - Deals and Alliances Profile
SummaryAbbVie Inc. (AbbVie) is a research-based biopharmaceutical company that carries out the resea...
24 Feb 2016 by Global Data USD $250 More Info
AbbVie Inc. (ABBV) - Financial and Strategic SWOT Analysis Review
AbbVie Inc. (ABBV) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic...
15 Dec 2015 by Global Data USD $300 More Info
AbbVie Inc. (ABBV) - Financial and Strategic SWOT Analysis Review
AbbVie Inc. (ABBV) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic...
01 Dec 2015 by Global Data USD $300 More Info
Physician Views: And then there were two – will AbbVie's 3-DA regimen prove a compelling competitor to Gilead's Harvoni?
Scope Later this month, the FDA is expected to approve AbbVie's oral '3-DA' product - comprising Vie...
11 Dec 2014 by FirstWord Pharma USD $695 More Info

This report is published by Global Data

Download Free Report Summary PDF

AbbVie Inc (ABBV) - Medical Equipment - Deals and Alliances Profile [Report Updated: 26-02-2018] | Download PDF Summary

Download our FREE report summary PDF. It contains all the information on these web pages, plus a Proforma Invoice request form, should you need it to satisfy your company's internal order procedures.

Ordering Information

Orders are processed immediately and you will be notified of the despatch date on confirmation of your order.

Accepted Card Types

Payment

Buy now using our secure payment system.

We Stock...

  • Allied Market Research
  • CBR Pharma
  • Current Partnering
  • Firstword
  • Global Data
  • Global Markets Direct
  • ICD Research
  • Infinti Research Technavio
  • Marketline
  • Markets and Markets
  • Micro Markets Monitor
  • MP Advisors
  • Venture Planning Group
  • GMR Data